Sanjiv.Parant.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE860D01013
  • NSEID:
  • BSEID: 531569
INR
167.10
-5.95 (-3.44%)
BSENSE

Nov 20

BSE+NSE Vol: 4.21 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 328426,
    "name": "Sanjiv.Parant.",
    "stock_name": "Sanjiv.Parant.",
    "full_name": "Sanjivani Paranteral Ltd",
    "name_url": "stocks-analysis/sanjivparant",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "167.10",
    "chg": -5.95,
    "chgp": "-3.44%",
    "dir": -1,
    "prev_price": "173.05",
    "mcapval": "217.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531569,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE860D01013",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "4.21 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/sanjivparant-328426-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sanjivani Paranteral Ltd Falls 2.39%: 2 Key Developments Shaping the Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sanjivani-paranteral-ltd-falls-239-2-key-developments-shaping-the-week-4270931",
        "imagepath": "",
        "date": "2026-11-22 10:00:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Valuation turns very attractive amid market pressure</p>\n                    <p><strong>19 Nov:</strong> MarketsMOJO upgrades rating to Buy on improved fundamentals</p>\n                    <p><strong>20 Nov:</strong> Stock closes at Rs.167.10, down 3.44% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.171.20</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.167.10</div><div class=\"stat-change negative\">-2.39%</div></div>\n                    <div class=\"sta..."
      },
      {
        "title": "Sanjivani Paranteral Ltd Upgraded to Buy on Improved Technicals and Financials",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/sanjivani-paranteral-ltd-upgraded-to-buy-on-improved-technicals-and-financials-4268763",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SanjivaniParant_mojoScore_4268763.png",
        "date": "2026-11-20 08:02:23",
        "description": "Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy by MarketsMojo as of 19 Nov 2026. This upgrade reflects a comprehensive reassessment across four key parameters: quality, valuation, financial trend, and technicals. The company’s improved technical indicators, fair valuation metrics, and robust financial performance underpin this positive outlook despite some near-term challenges."
      },
      {
        "title": "Sanjivani Paranteral Ltd Valuation Turns Very Attractive Amid Market Pressure",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sanjivani-paranteral-ltd-valuation-turns-very-attractive-amid-market-pressure-4262903",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SanjivaniParant_valuationdot_4262903.png",
        "date": "2026-11-16 08:00:30",
        "description": "Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a fair to a very attractive rating. This change reflects a significant reassessment of the company’s price attractiveness relative to its historical averages and peer group, despite recent stock price softness and sector headwinds."
      },
      {
        "title": "Sanjivani Paranteral Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/sanjivani-paranteral-ltd-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4260024",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SanjivaniParant_mojoScore_4260024.png",
        "date": "2026-11-13 08:03:30",
        "description": "Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 12 Nov 2026. This adjustment reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite strong quarterly financials and operational efficiency, the stock’s technical indicators and relative valuation have prompted a more cautious stance."
      },
      {
        "title": "Sanjivani Paranteral Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/sanjivani-paranteral-ltd-is-rated-hold-by-marketsmojo-4241899",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SanjivaniParant_mojoScore_4241899.png",
        "date": "2026-10-28 10:10:44",
        "description": "Sanjivani Paranteral Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 October 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Sanjivani Paranteral Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sanjivani-paranteral-ltd-valuation-shifts-signal-renewed-price-attractiveness-4239836",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SanjivaniParant_valuationdot_4239836.png",
        "date": "2026-10-27 08:00:24",
        "description": "Sanjivani Paranteral Ltd has witnessed a significant improvement in its valuation parameters, shifting from a fair to a very attractive rating. This change comes amid a challenging market backdrop where the stock has underperformed the Sensex over recent periods, yet shows compelling long-term returns and a favourable valuation relative to its pharmaceutical peers."
      },
      {
        "title": "Sanjivani Paranteral Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/sanjivani-paranteral-ltd-is-rated-hold-by-marketsmojo-4228459",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SanjivaniParant_mojoScore_4228459.png",
        "date": "2026-10-17 10:10:05",
        "description": "Sanjivani Paranteral Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 17 October 2026, providing investors with the most recent insights into its performance and outlook."
      },
      {
        "title": "Sanjivani Paranteral Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sanjivani-paranteral-ltd-valuation-shifts-signal-changing-market-sentiment-4227029",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SanjivaniParant_valuationdot_4227029.png",
        "date": "2026-10-16 08:00:21",
        "description": "Sanjivani Paranteral Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, reflecting evolving market perceptions amid mixed financial signals. This micro-cap pharmaceutical player’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios have risen significantly, prompting a reassessment of its price attractiveness relative to peers and historical benchmarks."
      },
      {
        "title": "Sanjivani Paranteral Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/sanjivani-paranteral-ltd-is-rated-hold-by-marketsmojo-4216253",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SanjivaniParant_mojoScore_4216253.png",
        "date": "2026-10-06 10:10:03",
        "description": "Sanjivani Paranteral Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 October 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing."
      }
    ],
    "total": 71,
    "sid": "328426",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/sanjivani-paranteral-328426"
  },
  "announcements": [
    {
      "caption": "Regulation 30 For In-Principle Approval",
      "datetime": "07-Nov-2026",
      "details": "Regulation 30 for In-Principle approval",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "06-Nov-2026",
      "details": "Investor Presentation for the Quarter ended 30th September 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Nov-2026",
      "details": "Newspaper Publication for the financial results ended 30th September 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sanjivani Paranteral Ltd has declared <strong>5%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Regulation 30 For In-Principle Approval

07-Nov-2026 | Source : BSE

Regulation 30 for In-Principle approval

Announcement under Regulation 30 (LODR)-Investor Presentation

06-Nov-2026 | Source : BSE

Investor Presentation for the Quarter ended 30th September 2026

Announcement under Regulation 30 (LODR)-Newspaper Publication

06-Nov-2026 | Source : BSE

Newspaper Publication for the financial results ended 30th September 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Sanjivani Paranteral Ltd has declared 5% dividend, ex-date: 19 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available